Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 6 , Pages 1047-1059, December 2008

The value of positron emission tomography (PET) in the management of patients with thyroid cancer

  • Richard J. Robbins, MD (Professor of Medicine, Weill Cornell Medical College; Chairman, Department of Medicine)

      Affiliations

    • Corresponding Author InformationCorresponding author.
  • Steven M. Larson, MD (Professor of Radiology, Weill Cornell Medical College; Chief, Nuclear Medicine Service)

Endocrine Division, Department of Medicine, The Methodist Hospital, Houston, TX 77030 Nuclear Medicine Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA

For more than a decade, positron emission tomography (PET) has had an important role in the management of thyroid cancer patients. It may be involved in initial, sometimes inadvertent, diagnosis; in postoperative evaluation; in detection of occult metastases; in the evaluation of thyroid nodules; and in prognostication of metastatic disease. In this review we will update the advances in the application of PET scanning to optimal patient management. The majority of the published studies to date have used 18F-fluoro-deoxyglucose (FDG) as the PET isotope, and unless specifically noted, all references to PET scanning will imply that this tracer has been used.

Key words: PET scanning, Thyroid cancer, Fluoro-deoxyglucose

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(08)00119-X

doi:10.1016/j.beem.2008.10.001

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 6 , Pages 1047-1059, December 2008